We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Higher Field Strengths and New Clinical Applications Increase Growth of MRI Systems

By MedImaging staff writers
Posted on 27 Jun 2007
Magnetic resonance imaging (MRI) is one of the most powerful and widely used diagnostic tools by clinicians today. More...
However, there are many challenges such as increasing pricing pressures, regulatory issues, and competition from computed tomography (CT) that need to be overcome in the European MRI systems market, according to a recent marketing report.

Despite these challenges, the market is expected to see growth. The scope for growth is related to the introduction of new applications. The market is not yet saturated and there are a few unexplored niche segments, which offer huge growth potential. Frost & Sullivan (Palo Alto, CA, USA), an international growth consultancy company, found that the European MRI market earned revenues of US$806.5 million in 2006 and estimates this to reach $1.03 billion in 2013.

"The European MRI systems market is primarily driven by the current wide variety of applications and constant development of new ones,” noted Frost & Sullivan research analyst B. Divya. "With continued upgrades in Tesla strength, the number of applications using MRI is increasing from the research point of view and is also becoming increasingly commercially viable.”

With advancements in neurologic, cardiac, and vascular, as well as breast MRI, the market is seeing growth essentially due to the application potential. Each new clinical application increases the usage of MRI systems. Moreover, high-field systems are expected to continue demonstrating strong growth, thereby replacing low-field systems.

However, the current state of the European healthcare system is restraining market growth. In addition, differing reimbursement policies in various geographic regions in the European Union are still another challenge. Furthermore, there is also the inherent challenge arising due to competition from CT.

"The European healthcare industry is experiencing severe financial constraints from having to support an aging population, with contributions from a small portion of working population,” explained Ms. Divya. "Consequently, the governments of various nations are wary of the fact that healthcare spending is exceedingly high, and one of the interesting ways in which nations are reducing healthcare costs is by simply not buying additional equipment.”

As the market is heading toward saturation, market participants will need to concentrate on niche segments. Targeting niche markets can be either through the acquisition of existing small local participants or through the introduction of new products.


Related Links:
Frost & Sullivan

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Blood Gas Analyzer
i-Check200
New
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Allevion Medical receives FDA Clearance for Vantage, introducing a fully disposable approach to minimally invasive spinal decompression (photo courtesy of Allevion Medical)

Single-Use System Enables Minimally Invasive Decompression for Lumbar Spinal Stenosis

Lumbar spinal stenosis is frequently driven by hypertrophic bone that narrows the canal and produces pain. Conventional decompression often relies on larger incisions and bulky retractors, adding time,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.